Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung CancerNeoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, bronchial disorder, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, metastatic melanoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasmRecruitingPhase 1 / Phase 22026-06-11NCT05361174

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Iovance Biotherapeutics, Inc.20

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Medical College of WisconsinMilwaukeeUnited States483
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Moffitt Cancer CenterTampaUnited States523
Orlando Health Cancer InstituteOrlandoUnited States1
Sylvester Comprehensive Cancer CenterMiamiUnited States37
The Angeles Clinic and Research InstituteLos AngelesUnited States16
The University of Kansas Cancer CenterWestwoodUnited States31
University of CincinnatiCincinnatiUnited States55
University of LouisvilleLouisvilleUnited States83
UPMC Hillman Cancer CenterPittsburghUnited States330
Weill Medical College of Cornell UniversityNew YorkUnited States2